AIM Health Group has several divisions that work closely with research and service sponsors over the last decade and a half. The clinical research division (Pharmaceutical Integrated Research Corporation – PIRC) is one of Canada’s fast growing research management organizations at Hospital based sites and at Community based sites. Further growth and opportunities are being leveraged through expansion into disciplines requiring research. Currently, PIRC has more than 70 active trial/site combinations at various stages. In addition, AIM is Canada’s leading provider of intravenous infusions, providing more than 26,000 infusions annually through its network of 37 clinical sites.
AIM Health Group has an established network of sites and also has an ever expanding network of collaborative partnerships in enhancing research, infusions and health care service delivery in Canada.
Clinical Research Leadership Team:
Dr. James Ducharme, Chief Medical Officer and Senior Vice-President
Dr. Jeffrey Balon, Medical Director PIRC - Community Based Trials
Dr. Tony Chris, Medical Director PIRC - Hospital Based Trials
Joanne Mabee, RPN, CCRP – Corporate CRC Manager – Community Based Research
Martine Cantin, RN, CRA – Original Research
|
